Zotiraciclib and its Impurities
Zotiraciclib also known as TG02 or SB1317. it is an investigational oral drug being developed for the treatment of aggressive cancers, particularly gliomas and other brain tumors. Reference standards of Zotiraciclib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.